232 related articles for article (PubMed ID: 15540201)
1. Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines.
Fujii C; Nakamoto Y; Lu P; Tsuneyama K; Popivanova BK; Kaneko S; Mukaida N
Int J Cancer; 2005 Mar; 114(2):209-18. PubMed ID: 15540201
[TBL] [Abstract][Full Text] [Related]
2. Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver.
Wu Y; Wang YY; Nakamoto Y; Li YY; Baba T; Kaneko S; Fujii C; Mukaida N
Oncogene; 2010 Apr; 29(15):2228-37. PubMed ID: 20101231
[TBL] [Abstract][Full Text] [Related]
3. Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell.
Gong J; Wang J; Ren K; Liu C; Li B; Shi Y
J Surg Res; 2009 May; 153(1):17-22. PubMed ID: 18675992
[TBL] [Abstract][Full Text] [Related]
4. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.
Li YY; Popivanova BK; Nagai Y; Ishikura H; Fujii C; Mukaida N
Cancer Res; 2006 Jul; 66(13):6741-7. PubMed ID: 16818649
[TBL] [Abstract][Full Text] [Related]
5. Roles of Pim-3, a novel survival kinase, in tumorigenesis.
Mukaida N; Wang YY; Li YY
Cancer Sci; 2011 Aug; 102(8):1437-42. PubMed ID: 21518143
[TBL] [Abstract][Full Text] [Related]
6. Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells.
Li YY; Wu Y; Tsuneyama K; Baba T; Mukaida N
Cancer Sci; 2009 Mar; 100(3):396-404. PubMed ID: 19154409
[TBL] [Abstract][Full Text] [Related]
7. Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis-inducing ability.
Li YY; Wang YY; Taniguchi T; Kawakami T; Baba T; Ishibashi H; Mukaida N
Int J Cancer; 2010 Jul; 127(2):474-84. PubMed ID: 19921695
[TBL] [Abstract][Full Text] [Related]
8. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression.
Zhang F; Liu B; Wang Z; Yu XJ; Ni QX; Yang WT; Mukaida N; Li YY
Mol Cancer Res; 2013 Dec; 11(12):1508-20. PubMed ID: 24165482
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1.
Liang H; Hittelman W; Nagarajan L
Arch Biochem Biophys; 1996 Jun; 330(2):259-65. PubMed ID: 8660654
[TBL] [Abstract][Full Text] [Related]
10. Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.
Liu B; Wang Z; Li HY; Zhang B; Ping B; Li YY
Oncol Rep; 2014 Jun; 31(6):2625-34. PubMed ID: 24789328
[TBL] [Abstract][Full Text] [Related]
11. Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis.
Kou T; Marusawa H; Kinoshita K; Endo Y; Okazaki IM; Ueda Y; Kodama Y; Haga H; Ikai I; Chiba T
Int J Cancer; 2007 Feb; 120(3):469-76. PubMed ID: 17066440
[TBL] [Abstract][Full Text] [Related]
12. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
13. Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis.
Popivanova BK; Li YY; Zheng H; Omura K; Fujii C; Tsuneyama K; Mukaida N
Cancer Sci; 2007 Mar; 98(3):321-8. PubMed ID: 17270021
[TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation.
Huang LR; Hsu HC
Cancer Res; 1995 Oct; 55(20):4717-21. PubMed ID: 7553654
[TBL] [Abstract][Full Text] [Related]
15. Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity.
Wang YY; Taniguchi T; Baba T; Li YY; Ishibashi H; Mukaida N
Cancer Sci; 2012 Jan; 103(1):107-15. PubMed ID: 21981263
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible enhancer/alpha-fetoprotein promoter-driven RNA interference targeting STK15 suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Gao P; Wang R; Shen JJ; Lin F; Wang X; Dong K; Zhang HZ
Cancer Sci; 2008 Nov; 99(11):2209-17. PubMed ID: 18803637
[TBL] [Abstract][Full Text] [Related]
18. Pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor.
Wang C; Li HY; Liu B; Huang S; Wu L; Li YY
J Surg Res; 2013 Dec; 185(2):595-604. PubMed ID: 23845873
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for hepatoma using a dual-function vector with both immunostimulatory and pim-3-silencing effects.
Guo Q; Lan P; Yu X; Han Q; Zhang J; Tian Z; Zhang C
Mol Cancer Ther; 2014 Jun; 13(6):1503-13. PubMed ID: 24723452
[TBL] [Abstract][Full Text] [Related]
20. A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma.
de Thé H; Marchio A; Tiollais P; Dejean A
Nature; 1987 Dec 17-23; 330(6149):667-70. PubMed ID: 2825037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
